Damilola A. Omoboyowa

According to our database, Damilola A. Omoboyowa authored at least 4 papers between 2023 and 2026.

Collaborative distances:

• Dijkstra number of six.
• Erdős number of five.

2026

Deep learning and molecular dynamics reveal promising EZH2 inhibitors for epigenetic cancer targeting.

Damilola A. Omoboyowa, Temitope C. Aribigbola, Babasola Aiyeku, Damilola S. Bodun, Oluwatoba E. Oyeneyin

Comput. Biol. Chem., 2026

2025

De novo design and bioactivity prediction of mitotic kinesin Eg5 inhibitors using MPNN and LSTM-based transfer learning.

Damilola S. Bodun, Isiaka O. Ibrahim, Mujeebat Bashiru, Rachael Oluwakamiye Abolade, Wilberforce K. Ndarawit, Adedoyin John-Joy Owolade, Temitope A. Ogunnupebi, Ibeh John Somtochukwu, Ezekiel A. Olugbogi, Katukoliya Gamage Anuththara Samadhi, Gbolahan O. Oduselu, Suliman Sharif, Damilola A. Omoboyowa, Olayinka O. Ajani

Comput. Biol. Medicine, 2025

2024

Integrating biocomputational techniques for Breast cancer drug discovery via the HER-2, BCRA, VEGF and ER protein targets.

Tope T. Odunitan, Oluwatosin A. Saibu, Boluwatife T. Apanisile, Damilola A. Omoboyowa, Toheeb A. Balogun, Adeyoola V. Awe, Temitope M. Ajayi, Grace V. Olagunju, Fatimah M. Mahmoud, Modinat Akinboade, Catherine B. Adeniji, Waliu O. Abdulazeez

Comput. Biol. Medicine, January, 2024

2023

QSAR-based virtual screening of traditional Chinese medicine for the identification of mitotic kinesin Eg5 inhibitors.

Damilola S. Bodun, Damilola A. Omoboyowa, Olaposi I. Omotuyi, Ezekiel A. Olugbogi, Toheeb A. Balogun, Chiamaka J. Ezeh, Emmanuel S. Omirin

Comput. Biol. Chem., June, 2023